- Home
- CCRD vs ACIU Comparison
CCRD vs ACIU Comparison
Compare CCRD & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCRD
- ACIU
- Stock Information
- Founded
- CCRD 1973
- ACIU 2003
- Country
- CCRD United States
- ACIU Switzerland
- Employees
- CCRD N/A
- ACIU N/A
- Industry
- CCRD
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- CCRD
- ACIU Health Care
- Exchange
- CCRD Nasdaq
- ACIU Nasdaq
- Market Cap
- CCRD 157.9M
- ACIU 189.1M
- IPO Year
- CCRD N/A
- ACIU 2016
- Fundamental
- Price
- CCRD $29.03
- ACIU $2.07
- Analyst Decision
- CCRD Hold
- ACIU Strong Buy
- Analyst Count
- CCRD 1
- ACIU 1
- Target Price
- CCRD $21.00
- ACIU $12.00
- AVG Volume (30 Days)
- CCRD 100.2K
- ACIU 125.1K
- Earning Date
- CCRD 07-31-2025
- ACIU 08-05-2025
- Dividend Yield
- CCRD N/A
- ACIU N/A
- EPS Growth
- CCRD 187.14
- ACIU N/A
- EPS
- CCRD 0.86
- ACIU N/A
- Revenue
- CCRD $61,011,000.00
- ACIU $32,014,254.00
- Revenue This Year
- CCRD $17.35
- ACIU N/A
- Revenue Next Year
- CCRD N/A
- ACIU $533.21
- P/E Ratio
- CCRD $33.15
- ACIU N/A
- Revenue Growth
- CCRD 12.31
- ACIU 91.20
- 52 Week Low
- CCRD $11.57
- ACIU $1.43
- 52 Week High
- CCRD $31.99
- ACIU $4.26
- Technical
- Relative Strength Index (RSI)
- CCRD 51.94
- ACIU 55.57
- Support Level
- CCRD $27.31
- ACIU $2.00
- Resistance Level
- CCRD $29.27
- ACIU $2.15
- Average True Range (ATR)
- CCRD 1.33
- ACIU 0.13
- MACD
- CCRD -0.24
- ACIU -0.01
- Stochastic Oscillator
- CCRD 36.85
- ACIU 80.92
About CCRD CoreCard Corporation
CoreCard Corp is engaged in the business of providing technology solutions and processing services to the financial technology and services market. It designs, develops and markets a comprehensive suite of software solutions to program managers, accounts receivable businesses, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, buy now pay later programs, loyalty programs and accounts receivable and loan transactions. The CoreCard software platform and modules include CoreENGINE, CoreISSUE, CoreFRAUD, CoreCOLLECT, CoreAPP, CoreMONEY and CoreACQUIRE. Its customers are located in the U.S, European Union and the Middle East of which key revenue is derived from the U.S.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.